+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Nucleic Acid Testing Market Research Report by Product, by Indication, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4968571
  • Report
  • July 2021
  • Region: Global
  • 195 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Nucleic Acid Testing Market will Grow to USD 4,607.45 Million by 2026, at a CAGR of 10.11%

FEATURED COMPANIES

  • 23andMe
  • Agendia BV
  • Autogenomics, Inc.
  • Cepheid
  • Hoffmann-La Roche Ltd
  • Nanostring Technologies
  • MORE
The Global Nucleic Acid Testing Market size was estimated at USD 2,585.05 Million in 2020 and expected to reach USD 2,837.68 Million in 2021, at a Compound Annual Growth Rate (CAGR) 10.11% to reach USD 4,607.45 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Nucleic Acid Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Nucleic Acid Testing Market was studied across Consumables and Nucleic Acid Test Kits.
  • Based on Technique, the Nucleic Acid Testing Market was studied across Probe Amplification Systems, Signal Amplification, and Target Amplification Systems.
  • Based on Indication, the Nucleic Acid Testing Market was studied across Cancer, Forensic Testing, Genetic & Mitochondrial Disorders, and Infectious Disease.
  • Based on End User, the Nucleic Acid Testing Market was studied across Hospitals, Pathology Laboratories, and Research Institutes.
  • Based on Region, the Nucleic Acid Testing Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Nucleic Acid Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Nucleic Acid Testing Market, including 23andMe, Abbott Molecular Inc., Affymetrix, Inc., Agendia BV, Agilent Technologies, Inc., ARUP LABARATORIES, ASURAGEN, INC., Autogenomics, Inc., Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Biomérieux SA, Cepheid, Dako Denmark A/S, Gen-Probe, Inc., Hoffmann-La Roche Ltd, Hologic, Inc., Illumina, Inc., INVIVOSCRIBE TECHNOLOGIES, INC, Nanostring Technologies, Novartis AG, Roche Diagnostics Corporation, Sequenom, Inc., Siemens Healthcare, Tecan Group Ltd., Ventana Medical Systems, Inc., Veridex, LLC., and Vysis.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Nucleic Acid Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Nucleic Acid Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Nucleic Acid Testing Market?
4. What is the competitive strategic window for opportunities in the Global Nucleic Acid Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Nucleic Acid Testing Market?
6. What is the market share of the leading vendors in the Global Nucleic Acid Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Nucleic Acid Testing Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 23andMe
  • Agendia BV
  • Autogenomics, Inc.
  • Cepheid
  • Hoffmann-La Roche Ltd
  • Nanostring Technologies
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Technique Outlook
3.5. Indication Outlook
3.6. End User Outlook
3.7. Region Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing use of nucleic acid-based tests for diagenetic preposes
5.1.1.2. Increased commercialization of human genetic tests
5.1.1.3. Pandemic control and eradication
5.1.2. Restraints
5.1.2.1. Huge expenditure on R&D
5.1.3. Opportunities
5.1.3.1. Attractive funding space and government support
5.1.3.2. Drug discovery and development
5.1.4. Challenges
5.1.4.1. Expensive instrumentation and technology level challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Nucleic Acid Testing Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Nucleic Acid Test Kits

7. Nucleic Acid Testing Market, by Technique
7.1. Introduction
7.2. Probe Amplification Systems
7.3. Signal Amplification
7.4. Target Amplification Systems

8. Nucleic Acid Testing Market, by Indication
8.1. Introduction
8.2. Cancer
8.3. Forensic Testing
8.4. Genetic & Mitochondrial Disorders
8.5. Infectious Disease

9. Nucleic Acid Testing Market, by End User
9.1. Introduction
9.2. Hospitals
9.3. Pathology Laboratories
9.4. Research Institutes

10. Americas Nucleic Acid Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Nucleic Acid Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Thailand

12. Europe, Middle East & Africa Nucleic Acid Testing Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. 23andMe
14.2. Abbott Molecular Inc.
14.3. Affymetrix, Inc.
14.4. Agendia BV
14.5. Agilent Technologies, Inc.
14.6. ARUP LABARATORIES
14.7. ASURAGEN, INC.
14.8. Autogenomics, Inc.
14.9. Beckman Coulter, Inc.
14.10. Becton Dickinson and Company
14.11. Bio-Rad Laboratories, Inc.
14.12. Biomérieux SA
14.13. Cepheid
14.14. Dako Denmark A/S
14.15. Gen-Probe, Inc.
14.16. Hoffmann-La Roche Ltd
14.17. Hologic, Inc.
14.18. Illumina, Inc.
14.19. INVIVOSCRIBE TECHNOLOGIES, INC
14.20. Nanostring Technologies
14.21. Novartis AG
14.22. Roche Diagnostics Corporation
14.23. Sequenom, Inc.
14.24. Siemens Healthcare
14.25. Tecan Group Ltd.
14.26. Ventana Medical Systems, Inc.
14.27. Veridex, LLC.
14.28. Vysis

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2020 (USD MILLION)
FIGURE 4. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 6. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 7. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL NUCLEIC ACID TESTING MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL NUCLEIC ACID TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 11. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2026
FIGURE 13. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CONSUMABLES, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY NUCLEIC ACID TEST KITS, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY NUCLEIC ACID TEST KITS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2020 VS 2026 (%)
FIGURE 18. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2020 VS 2026 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2026
FIGURE 20. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PROBE AMPLIFICATION SYSTEMS, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PROBE AMPLIFICATION SYSTEMS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SIGNAL AMPLIFICATION, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SIGNAL AMPLIFICATION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TARGET AMPLIFICATION SYSTEMS, 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TARGET AMPLIFICATION SYSTEMS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 26. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2020 VS 2026 (%)
FIGURE 27. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2020 VS 2026 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2026
FIGURE 29. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CANCER, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 31. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY FORENSIC TESTING, 2018-2026 (USD MILLION)
FIGURE 32. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 33. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY GENETIC & MITOCHONDRIAL DISORDERS, 2018-2026 (USD MILLION)
FIGURE 34. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY GENETIC & MITOCHONDRIAL DISORDERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 35. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2026 (USD MILLION)
FIGURE 36. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 37. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 38. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2026
FIGURE 40. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 42. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PATHOLOGY LABORATORIES, 2018-2026 (USD MILLION)
FIGURE 43. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PATHOLOGY LABORATORIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 44. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 45. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 46. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. CANADA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. MEXICO NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. CHINA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. INDIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. JAPAN NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. THAILAND NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. FRANCE NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. GERMANY NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. ITALY NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. QATAR NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. SPAIN NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. GLOBAL NUCLEIC ACID TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 76. GLOBAL NUCLEIC ACID TESTING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NUCLEIC ACID TESTING MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL NUCLEIC ACID TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY NUCLEIC ACID TEST KITS, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PROBE AMPLIFICATION SYSTEMS, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SIGNAL AMPLIFICATION, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TARGET AMPLIFICATION SYSTEMS, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY GENETIC & MITOCHONDRIAL DISORDERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PATHOLOGY LABORATORIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. CANADA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. MEXICO NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. CHINA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. INDIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. JAPAN NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. THAILAND NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. FRANCE NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. GERMANY NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. ITALY NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. QATAR NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. SPAIN NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. GLOBAL NUCLEIC ACID TESTING MARKET: SCORES
TABLE 50. GLOBAL NUCLEIC ACID TESTING MARKET: BUSINESS STRATEGY
TABLE 51. GLOBAL NUCLEIC ACID TESTING MARKET: PRODUCT SATISFACTION
TABLE 52. GLOBAL NUCLEIC ACID TESTING MARKET: RANKING
TABLE 53. GLOBAL NUCLEIC ACID TESTING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 54. GLOBAL NUCLEIC ACID TESTING MARKET: MERGER & ACQUISITION
TABLE 55. GLOBAL NUCLEIC ACID TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 56. GLOBAL NUCLEIC ACID TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 57. GLOBAL NUCLEIC ACID TESTING MARKET: INVESTMENT & FUNDING
TABLE 58. GLOBAL NUCLEIC ACID TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 59. GLOBAL NUCLEIC ACID TESTING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • 23andMe
  • Abbott Molecular Inc.
  • Affymetrix, Inc.
  • Agendia BV
  • Agilent Technologies, Inc.
  • ARUP LABARATORIES
  • ASURAGEN, INC.
  • Autogenomics, Inc.
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomérieux SA
  • Cepheid
  • Dako Denmark A/S
  • Gen-Probe, Inc.
  • Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Illumina, Inc.
  • INVIVOSCRIBE TECHNOLOGIES, INC
  • Nanostring Technologies
  • Novartis AG
  • Roche Diagnostics Corporation
  • Sequenom, Inc.
  • Siemens Healthcare
  • Tecan Group Ltd.
  • Ventana Medical Systems, Inc.
  • Veridex, LLC.
  • Vysis
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll